BFC Planning’s Dianthus Therapeutics DNTH Stock Holding History
Bought
Maintained
Sold
Other funds holding DNTH
BFC Planning's DNTH Position: Q3 2026 in Review
BFC Planning opened a new position in Dianthus Therapeutics (DNTH) in Q3 2026: 14 shares worth $1.23K. The stake represents ﹤0.01% of the portfolio and ranks #3122 among its holdings.
188 funds tracked by Wall St. Rank hold DNTH as of Q3 2026.
- BFC Planning held 14 shares of Dianthus Therapeutics worth $1.23K as of Q3 2026.
- Dianthus Therapeutics was a new BFC Planning position in Q3 2026.
- Dianthus Therapeutics made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #3122 holding.
- 188 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q3 2026.
Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.